Jeffrey Robert Ajer - Net Worth and Insider Trading
Jeffrey Robert Ajer Net Worth
The estimated net worth of Jeffrey Robert Ajer is at least $4 Million dollars as of 2024-11-29. Jeffrey Robert Ajer is the EVP, Chief Commercial Officer of Biomarin Pharmaceutical Inc and owns about 66,767 shares of Biomarin Pharmaceutical Inc (BMRN) stock worth over $4 Million. Jeffrey Robert Ajer is also the Director of Nektar Therapeutics and owns about 34,153 shares of Nektar Therapeutics (NKTR) stock worth over $38,593. Details can be seen in Jeffrey Robert Ajer's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jeffrey Robert Ajer has not made any transactions after 2024-05-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jeffrey Robert Ajer
Jeffrey Robert Ajer Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jeffrey Robert Ajer owns 2 companies in total, including Biomarin Pharmaceutical Inc (BMRN) , and Nektar Therapeutics (NKTR) .
Click here to see the complete history of Jeffrey Robert Ajer’s form 4 insider trades.
Insider Ownership Summary of Jeffrey Robert Ajer
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BMRN | Biomarin Pharmaceutical Inc | 2024-05-02 | EVP & Chief Commercial Officer |
| NKTR | Nektar Therapeutics | 2023-09-18 | director |
Jeffrey Robert Ajer Latest Holdings Summary
Jeffrey Robert Ajer currently owns a total of 2 stocks. Among these stocks, Jeffrey Robert Ajer owns 66,767 shares of Biomarin Pharmaceutical Inc (BMRN) as of May 2, 2024, with a value of $4 Million and a weighting of 99.12%. Jeffrey Robert Ajer also owns 34,153 shares of Nektar Therapeutics (NKTR) as of September 18, 2023, with a value of $38,593 and a weighting of 0.88%.
Latest Holdings of Jeffrey Robert Ajer
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BMRN | Biomarin Pharmaceutical Inc | 2024-05-02 | 66,767 | 65.42 | 4,367,897 |
| NKTR | Nektar Therapeutics | 2023-09-18 | 34,153 | 1.13 | 38,593 |
Holding Weightings of Jeffrey Robert Ajer
Jeffrey Robert Ajer Form 4 Trading Tracker
According to the SEC Form 4 filings, Jeffrey Robert Ajer has made a total of 20 transactions in Biomarin Pharmaceutical Inc (BMRN) over the past 5 years, including 0 buys and 20 sells. The most-recent trade in Biomarin Pharmaceutical Inc is the sale of 5,000 shares on May 2, 2024, which brought Jeffrey Robert Ajer around $414,550.
According to the SEC Form 4 filings, Jeffrey Robert Ajer has made a total of 5 transactions in Nektar Therapeutics (NKTR) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Nektar Therapeutics is the sale of 4,359 shares on September 18, 2023, which brought Jeffrey Robert Ajer around $3,008.
Insider Trading History of Jeffrey Robert Ajer
- 1
Jeffrey Robert Ajer Trading Performance
Jeffrey Robert Ajer Ownership Network
Jeffrey Robert Ajer Owned Company Details
What does Biomarin Pharmaceutical Inc do?
Who are the key executives at Biomarin Pharmaceutical Inc?
Jeffrey Robert Ajer is the EVP & Chief Commercial Officer of Biomarin Pharmaceutical Inc. Other key executives at Biomarin Pharmaceutical Inc include EVP & Chief Technical Officer Charles Greg Guyer , GVP & Chief Accounting Officer Erin Burkhart , and EVP & Chief Financial Officer Brian Mueller .
Biomarin Pharmaceutical Inc (BMRN) Insider Trades Summary
Over the past 18 months, Jeffrey Robert Ajer made 3 insider transaction in Biomarin Pharmaceutical Inc (BMRN) with a net sale of 14,000. Other recent insider transactions involving Biomarin Pharmaceutical Inc (BMRN) include a net sale of 153,000 shares made by Jean Jacques Bienaime , a net sale of 92,066 shares made by George Eric Davis , and a net sale of 47,341 shares made by Henry J Fuchs .
In summary, during the past 3 months, insiders sold 5,278 shares of Biomarin Pharmaceutical Inc (BMRN) in total and bought 0 shares, with a net sale of 5,278 shares. During the past 18 months, 325,045 shares of Biomarin Pharmaceutical Inc (BMRN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 325,045 shares.
Biomarin Pharmaceutical Inc (BMRN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Biomarin Pharmaceutical Inc Insider Transactions
Jeffrey Robert Ajer Mailing Address
Above is the net worth, insider trading, and ownership report for Jeffrey Robert Ajer. You might contact Jeffrey Robert Ajer via mailing address: C/o Biomarin Pharmaceutical Inc., 105 Digital Drive, Novato Ca 94949.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
